FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003309503> ?p ?o ?g. }

• W2003309503 endingPage "3120" @default.
• W2003309503 startingPage "3114" @default.
• W2003309503 abstract "OBJECTIVE Although statins can induce coronary atheroma regression, this benefit has yet to be demonstrated in diabetic individuals. We tested the hypothesis that high-intensity statin therapy may promote coronary atheroma regression in patients with diabetes. RESEARCH DESIGN AND METHODS The Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin (SATURN) used serial intravascular ultrasound measures of coronary atheroma volume in patients treated with rosuvastatin 40 mg or atorvastatin 80 mg for 24 months. This analysis compared changes in biochemistry and coronary percent atheroma volume (PAV) in patients with (n = 159) and without (n = 880) diabetes. RESULTS At baseline, patients with diabetes had lower LDL cholesterol (LDL-C) and HDL cholesterol (HDL-C) levels but higher triglyceride and CRP levels compared with patients without diabetes. At follow-up, diabetic patients had lower levels of LDL-C (61.0 ± 20.5 vs. 66.4 ± 22.9 mg/dL, P = 0.01) and HDL-C (46.3 ± 10.6 vs. 49.9 ± 12.0 mg/dL, P &lt; 0.001) but higher levels of triglycerides (127.6 [98.8, 163.0] vs. 113.0 mg/dL [87.6, 151.9], P = 0.001) and CRP (1.4 [0.7, 3.3] vs. 1.0 [0.5, 2.1] mg/L, P = 0.001). Both patients with and without diabetes demonstrated regression of coronary atheroma as measured by change in PAV (−0.83 ± 0.13 vs. −1.15 ± 0.13%, P = 0.08). PAV regression was less in diabetic compared with nondiabetic patients when on-treatment LDL-C levels were &gt;70 mg/dL (−0.31 ± 0.23 vs. −1.01 ± 0.21%, P = 0.03) but similar when LDL-C levels were ≤70 mg/dL (−1.09 ± 0.16 vs. −1.24 ± 0.16%, P = 0.50). CONCLUSIONS High-intensity statin therapy alters the progressive nature of diabetic coronary atherosclerosis, yielding regression of disease in diabetic and nondiabetic patients." @default.
• W2003309503 created "2016-06-24" @default.
• W2003309503 creator A5001116847 @default.
• W2003309503 creator A5006942246 @default.
• W2003309503 creator A5038853280 @default.
• W2003309503 creator A5040589473 @default.
• W2003309503 creator A5043201732 @default.
• W2003309503 creator A5048010077 @default.
• W2003309503 creator A5052604218 @default.
• W2003309503 creator A5053718870 @default.
• W2003309503 creator A5055849986 @default.
• W2003309503 creator A5061389868 @default.
• W2003309503 creator A5065286313 @default.
• W2003309503 creator A5073635316 @default.
• W2003309503 creator A5078366960 @default.
• W2003309503 creator A5087247030 @default.
• W2003309503 date "2014-10-10" @default.
• W2003309503 modified "2023-10-18" @default.
• W2003309503 title "High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN" @default.
• W2003309503 cites W1502524639 @default.
• W2003309503 cites W1526927233 @default.
• W2003309503 cites W172609984 @default.
• W2003309503 cites W179769568 @default.
• W2003309503 cites W1972661406 @default.
• W2003309503 cites W2012928569 @default.
• W2003309503 cites W2043279062 @default.
• W2003309503 cites W2054455620 @default.
• W2003309503 cites W2078233084 @default.
• W2003309503 cites W2097870088 @default.
• W2003309503 cites W2098364806 @default.
• W2003309503 cites W2105049460 @default.
• W2003309503 cites W2106289087 @default.
• W2003309503 cites W2107295258 @default.
• W2003309503 cites W2111412070 @default.
• W2003309503 cites W2112618189 @default.
• W2003309503 cites W2127933204 @default.
• W2003309503 cites W2139168645 @default.
• W2003309503 cites W2144107403 @default.
• W2003309503 cites W2145478166 @default.
• W2003309503 cites W2146228563 @default.
• W2003309503 cites W2159449551 @default.
• W2003309503 cites W2164089346 @default.
• W2003309503 cites W2166910397 @default.
• W2003309503 cites W2331274940 @default.
• W2003309503 cites W2337454357 @default.
• W2003309503 cites W3021842026 @default.
• W2003309503 cites W60172896 @default.
• W2003309503 doi "https://doi.org/10.2337/dc14-1121" @default.
• W2003309503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25190674" @default.
• W2003309503 hasPublicationYear "2014" @default.
• W2003309503 type Work @default.
• W2003309503 sameAs 2003309503 @default.
• W2003309503 citedByCount "49" @default.
• W2003309503 countsByYear W20033095032014 @default.
• W2003309503 countsByYear W20033095032015 @default.
• W2003309503 countsByYear W20033095032016 @default.
• W2003309503 countsByYear W20033095032017 @default.
• W2003309503 countsByYear W20033095032018 @default.
• W2003309503 countsByYear W20033095032019 @default.
• W2003309503 countsByYear W20033095032020 @default.
• W2003309503 countsByYear W20033095032021 @default.
• W2003309503 countsByYear W20033095032022 @default.
• W2003309503 crossrefType "journal-article" @default.
• W2003309503 hasAuthorship W2003309503A5001116847 @default.
• W2003309503 hasAuthorship W2003309503A5006942246 @default.
• W2003309503 hasAuthorship W2003309503A5038853280 @default.
• W2003309503 hasAuthorship W2003309503A5040589473 @default.
• W2003309503 hasAuthorship W2003309503A5043201732 @default.
• W2003309503 hasAuthorship W2003309503A5048010077 @default.
• W2003309503 hasAuthorship W2003309503A5052604218 @default.
• W2003309503 hasAuthorship W2003309503A5053718870 @default.
• W2003309503 hasAuthorship W2003309503A5055849986 @default.
• W2003309503 hasAuthorship W2003309503A5061389868 @default.
• W2003309503 hasAuthorship W2003309503A5065286313 @default.
• W2003309503 hasAuthorship W2003309503A5073635316 @default.
• W2003309503 hasAuthorship W2003309503A5078366960 @default.
• W2003309503 hasAuthorship W2003309503A5087247030 @default.
• W2003309503 hasBestOaLocation W20033095031 @default.
• W2003309503 hasConcept C126322002 @default.
• W2003309503 hasConcept C134018914 @default.
• W2003309503 hasConcept C164705383 @default.
• W2003309503 hasConcept C2776839432 @default.
• W2003309503 hasConcept C2776931568 @default.
• W2003309503 hasConcept C2777482532 @default.
• W2003309503 hasConcept C2778213512 @default.
• W2003309503 hasConcept C2779318932 @default.
• W2003309503 hasConcept C2780499067 @default.
• W2003309503 hasConcept C2991716557 @default.
• W2003309503 hasConcept C555293320 @default.
• W2003309503 hasConcept C71924100 @default.
• W2003309503 hasConceptScore W2003309503C126322002 @default.
• W2003309503 hasConceptScore W2003309503C134018914 @default.
• W2003309503 hasConceptScore W2003309503C164705383 @default.
• W2003309503 hasConceptScore W2003309503C2776839432 @default.
• W2003309503 hasConceptScore W2003309503C2776931568 @default.
• W2003309503 hasConceptScore W2003309503C2777482532 @default.
• W2003309503 hasConceptScore W2003309503C2778213512 @default.
• W2003309503 hasConceptScore W2003309503C2779318932 @default.

• next